Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Medical’s control valve

This article was originally published in The Gray Sheet

Executive Summary

VP-Corporate Relations Peter Gove departs May 12 to pursue "other personal, community and business interests," the exec says. An 11-year St. Jude veteran, Gove also vacates his post as president of the St. Jude Medical Foundation and treasurer of the firm's political action committee. St. Jude will subsequently create VP positions for government affairs and communications. Gove sits on QRS Diagnostic's board...

You may also be interested in...



People In Brief

St. Jude Medical: Angie Craig, Smith & Nephew VP-U.S. investor & media relations, is leaving the orthopedics manufacturer this month to take over the VP-communications spot at St. Jude May 1. Craig will assume much of the work currently handled by VP-Corporate Relations Pete Gove, who will depart May 12 to pursue "other personal, community and business interests" (1"The Gray Sheet" March 24, 2005, In Brief). St. Jude Investor Relations Director Laura Merriam will report to Craig. Separately, St. Jude plans to hire a VP-government affairs to fill Gove's public policy duties, which include president of the St. Jude Medical Foundation and treasurer of the firm's political action committee. Smith & Nephew plans to recruit a replacement for Craig in the near future...

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021783

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel